The market for antibiotics will grow by 5.11% YO-Y in 2022-2023. This is due to the rising prevalence of infectious diseases.

NEW YORK, Jan. 9, 2023 /PRNewswire/ —

Market research on antibiotics

• Vendors: 15+, Including Abbott Laboratories, AbbVie Inc., Armata Pharmaceuticals Inc., Aspen Pharmacare Holdings Ltd, Astellas Pharma Inc., Aurobindo Pharma Ltd., Bayer AG, F. Hoffmann La Roche Ltd., Flynn Pharma Ltd., GlaxoSmithKline Ltd., Incepta Pharmaceuticals Ltd., Johnson and Johnson, Lupin Ltd., Mayne Pharma Group Ltd., Melinta Therapeutics Ltd., Sanofi SA, Takeda Pharmaceutical Co. Ltd. Ltd. Ltd. Ltd. Ltd. Ltd. Ltd. Ltd. Ltd. Ltd. Ltd., and Teva Pharmaceutical Industry Ltd.

• Coverage: Analysis of the parent market; key trends and challenges; customer landscape; insights into vendor products and recent developments; key vendors; market positioning for vendors

• Segments: Product (broad and narrow-spectrum antibiotics and oral antibiotics), route (intravenous and oral), and geographyAsia, North America, Europe, and Rest of World

Learn more about the market for antibiotics request a sample report

The market report on antibiotics provides important information and factual facts, as well as a qualitative analysis of the market that focuses on market drivers, limitations, and future perspectives.

Why buy?

• Strategy credibility

• Analyze the offerings of competitor companies

• Get a complete view of the market

Technavio – Maximize your profit margin Buy the Report

The 2017 market for antibiotics was valued at USD 40.633.93 millions. A regional perspective Asia Tend the largest market share valued at USD 14,893.29 Million. The antibiotics market It is predicted that the size will increase by USD 17,066.66 millions From 2022 to 2027 at an CAGR of 6.07% Technavio.

Antibiotics market – Customer landscape
To help companies evaluate and develop growth strategies, the report outlines –

• Important purchase criteria

• Adoption rates

• Adoption lifecycle

• Factors that drive price sensitivity

• For more information on the customer landscape analysis, click here download a sample!

Global antibiotics market – Vendor insights

Vendors must adopt various growth strategies, including promotional activities and advertising to boost their visibility. Technavio’s market analysis report provides detailed information about several market vendors, including –

• AbbVie Inc: HUMIRA, a pain-relieving antibiotic, is offered by the company.

• Astellas Pharma Inc: XTANDI, a prescription drug that treats prostate cancer, is offered by the company.

• Aspen Pharmacare Holdings Ltd: Aggrastat, an antibiotic medication which treats symptoms of heart attacks and blood clots, is offered by the company.

Global antibiotics market – Market dynamics

Major drivers-

• Infectious diseases are on the rise

• Awareness and treatment of many diseases is increasing

• Special regulatory designations

KEY challenges – 

Drivers, & Challenges have an impact on market dynamics and can impact businesses. Find some insights from a sample report!

What key data is included in this report?

• The market’s CAGR for the forecast period

• Get detailed information about the factors that will determine the growth and future prospects of the antibiotics industry between 2023-2027

• Estimate the size and contribution of the antibiotics market to the parent market

• Forecasts of the future and changes in consumer behavior are accurate

• Market growth for antibiotics across the board Asia, North America, Europe, and Rest of World

• Market analysis and details about vendors

• Analyse in depth of all factors that may hinder the growth and expansion of the antibiotics market vendors

Get instant access to over 17,000+ market research reports. 

Technavio’s SUBSCRIPTION platform

Similar Reports

Anti-inflammatory Therapeutics Market Forecast and Analysis 2023-2027 – By Application, Drug Type, and Geography It is expected that the market for anti-inflammatory therapies will grow to approximately Grow At a CAGR 6.7% Between 2022 and 2027 It is predicted that the market will grow in size by USD 39.32 trillion. The market growth is largely driven by the unmet demand for safer biologics for RA, though factors like the loss patents may slow market growth.

Anti-obesity Drugs Market Forecast and Analysis 2023-2027 by Type, Drug Class, and Geographic: Anti-obesity drugs are expected to grow at an annual rate of a CAGR of 12.5% Between 2022 and 2027 It is predicted that the market will grow in size by USD 13,693.43 millions. The growing obese population is notably driving the market growth, although factors such as limited reimbursement for anti-obesity drugs may impede the market growth.

Technavio is available for purchaseHealth Care“Research Reports

Table of Contents

1 Executive Summary

2 Market Landscape

3 Market Sizing

4 Historic Market Size

Analysis of 5 Five Forces

6 Market Segmentation By Product

7 Market Segmentation By Route of Administration

8 Customer Landscapes

9 Geographic Landscapes

Ten Trends, Challenges, And Drivers

11 Vendor Landscape

12 Vendor Analysis

13 Appendix

About Us
Technavio is a world-leading technology advisory and research company. Technavio’s research and analysis focus on emerging market trends. They provide actionable insights that help businesses identify potential market opportunities and create effective strategies to maximize their market position. Technavio has over 500 analysts who specialize in 800 technologies. Their report library covers more than 17,000 topics and is growing. Technavio’s client base includes enterprises of all sizes and more than 100 Fortune 500 businesses. Technavio’s broad coverage, extensive research, actionable market insight, and extensive market research are the key ingredients of this expanding client base. They help clients identify and assess opportunities in current and potential markets as well as evaluate their competitive positions in changing market environments.

Get in touch
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: [email protected]
Website: www.technavio.com/

Download multimedia from original content:https://www.prnewswire.com/news-releases/antibiotics-market-to-grow-by-5-11-y-o-y-from-2022-to-2023-rising-prevalence-of-infectious-diseases-will-drive-growth—technavio-301714335.html

Technavio – SOURCE